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Raw data for NRR proteolysis as a function of time at different forces. Duplicate or triplicate curves were recorded in the presence (A17) or absence (mock) of Adam17 at four different forces. Data traces shown start at the time when force is applied. Number of beads was normalized to fraction of beads remaining by dividing by the total number of beads at the first time point in the experiment, which varied slightly from experiment to experiment, typically 100 to 300 beads.
These curves were averaged and standard error bars shown in light grey. The averaged mock curve for each force was subtracted from the averaged trace in the presence of enzyme. Cells were recovered 48 hours after transfection, and surface levels of the chimeric ligands were analyzed using flow cytometry by detection of an HA epitope tag with an anti-HA antibody, followed by treatment with a FITCconjugated anti-mouse secondary antibody. Plots show the fluorescence histogram.
Supplemental Experimental Procedures
Constructs. The sequence of the human Notch1 NRR (amino acid residues 1426-1733) was first amplified using primers that also introduced a 5' Nhe1 site, and a 3' Bsu36i site followed by an Avi tag and a stop codon, and then inserted into the pM-Mammalian Secretory SUMOstar vector (Lifesensors) using InFusion cloning (Clontech). Plasmids for expression of the positive (AV) and negative (AG) control peptides (NIPYKIEAVQS and NIPYKIEAGQS, respectively) were assembled by inserting the sequences encoding the peptides between the Nhe1 and Bsu36i sites. The catalytic domain of murine Adam17 (residues 1-477) was amplified by PCR using primers that incorporated a C-terminal His 8 tag, and subcloned into pcDNA3 The sequence encoding BirA was amplified from a commercial BirA vector (Avidity) using primers that introduced a C-terminal KDEL sequence followed by a stop codon, and inserted into pcDNA3.1 behind an Nterminal Notch1 signal sequence. Various Notch1-Gal4 cDNAs were assembled by derivatizing previously described Notch1-Gal4 expression constructs (Malecki et al., 2006 ). An Avi tag was also incorporated between the HA tag and the first EGF repeat of the Notch1 coding sequence. FRB-Notch1-Gal4 was prepared by substituting a fragment encoding the FRB domain (the FRB template was a kind further purification by size exclusion chromatography on an S200 column. The Adam17 catalytic domain was secreted into the conditioned media of 293T cells and purified using Ni-NTA affinity chromatography. Eluted protein was passed through a concentrator with a MW cutoff of 100,000 Daltons, which was washed with Tris buffer (50 mM, pH 8) containing 150 mM NaCl, and 5 µM ZnCl 2 . The flowthrough and wash were combined and concentrated using a concentrator with a MW cutoff of 10,000 Daltons and further purified by size exclusion using an S200 column. Activity assays of recombinant and commercially supplied (R&D Systems) Adam17 ( Figure S1 ) were performed using the recommended fluorogenic peptide (R&D Systems), and fluorescence was recorded using a beads were flowed in to ensure that the surface was properly blocked-generally only 1-2 beads stuck non-specifically. The channel was washed again with working buffer. SUMO-X-biotin was added to 500 µL working buffer containing 1 mM CaCl 2 at a concentration of about 5-100 pM and drawn into the flow cell at 0.025 ml min -1 with a syringe pump (Harvard Apparatus 11 Plus), allowing binding of SUMO-X-biotin to immobilized streptavidin sites. To minimize the probability of multiple tethers to a given bead, the optimal concentration of SUMO-X-biotin was determined for each protein prep by first flowing in 5 pM of protein, followed by beads, and increasing the concentration until the optimal field of about 200 beads at 10x (~1mm 2 field of view) was achieved. A stock of α-SUMO antibody-functionalized polystyrene beads (tosyl-activated, 2.8-µm diameter; Dynal) was prepared as previously described (Tanner and van Oijen, 2010) . A 2 µL bead stock was diluted with 500 µL HBS-P buffer containing Surfactant P20 (GE Healthcare) and drawn into the flow cell at 0.015 ml min -1 to specifically bind the SUMO-labelled substrates. Excess beads were removed from the flow cell by washing with 0.5 mL working buffer plus calcium at 0.025 ml min -1 .
When the volume of buffer was reduced to 30 µl, the flow was stopped and 30 µl of working buffer plus calcium containing Adam17 (1 µM), and ZnCl 2 (4 µM) was added. For peptide experiments, the magnet was lowered to a distance corresponding to 1 or 5.4 pN of force. The solution containing Adam17 was loaded at a rate of 0.008 ml min -1 and flow stopped after the enzyme was loaded (~ 7 minutes). Movies were recorded using Metavue or MicroManager in onesecond increments for 15-30 minutes. The total number of beads in each frame and rapamycin (100-500 nM final concentration) as indicated) were added. On day 3, the luciferase reporter activity was determined using a Promega Dual Luciferase kit.
Western blots. Plated ligand assays. On Day 1, U2OS cells stably expressing full-length Notch1/Gal4 or FRB-Notch1/Gal4 were plated into Uplift dishes (Thermo) in order to avoid the use of trypsinization during transfer onto ligandcoated wells. Doxycycline was added to a final concentration of 1 µm. Ligand or non-native ligand (300 µL at 10 µg/ml in PBS buffer) was immobilized on 12 well plates overnight at room temperature. On day 2, Notch-expressing cell lines were allowed to "uplift" from Thermo plates and cells were transferred to the plates with immobilized ligand (in the presence of 400 nM Compound E and 100-500 nM rapamycin as indicated). Three hours later, RIPAA buffer minus SDS plus protease inhibitors was added, and the plates were kept at 4 C for 20 minutes before the lysates were subjected to SDS-PAGE and Western blotting.
The anti-V1744 antibody (Cell Signaling) was used at 1:1000 dilution and the anti-Notch1-TAD antibody (Wang et al., 2011 ) was used at 1:5000.
Co-culture assays. On Day 1, U2OS cells stably expressing full-length Notch1/Gal4 or FRB-Notch1/Gal4 were plated into 12 well plates and doxycycline was added at a final concentration of 1 µm. Ligands were reverse transfected into 293T cells in 12 well plates (1mg/well). On day 3, ligand-expressing cells were resuspended in fresh media, and co-cultured with the Notch cells. The plate was centrifuged briefly at 500 g for 3 minutes after adding ligand cells. In experiments using the endocytois inhibitor, hydroxydynasore, co-culture of all ligand-expressing cells was performed in serum-free DMEM. Hydroxydynasore was used at a concentration of 30 µM. Three hours after the initiation of coculture, cells were lysed with RIPAA buffer and Western blotting was performed as above.
